MediciBIO Co.
Latest round
- Series A
Last raised
- Sep 2026
Total raised
- $3.3M
Investors
- 3
About MediciBIO Co.
, Ltd. operates as a company that develops lipid nanoparticle drug delivery technologies for gene-based medicines. The company creates proprietary lipid carriers that improve the delivery of RNA and DNA therapies, vaccines, and treatments for genetic diseases while aiming to reduce immune reactions and side effects.
Who invested in MediciBIO Co.
3 investors across 1 round
See all investors in MediciBIO Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 22, 2026
Amount
$3.3M
Investors
Questions about MediciBIO Co.
Who invested in MediciBIO Co.?
MediciBIO Co. has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MediciBIO Co. raised?
MediciBIO Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did MediciBIO Co. last raise money?
MediciBIO Co.'s most recent round on record is a Series A, in Sep 2026.
What does MediciBIO Co. do?
MediciBIO Co. is a biotechnology company.
Where is MediciBIO Co. headquartered?
MediciBIO Co. is headquartered in Yongin, South Korea.
Which VCs invest in companies like MediciBIO Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at MediciBIO Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like MediciBIO Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.